The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Serum hyaluronate in primary biliary cirrhosis–a biochemical marker for progressive liver damage
Abstract
To evaluate serum hyaluronate as a marker for progressive liver injury in patients with primary biliary cirrhosis, a longitudinal study including 48 patients was conducted with a mean follow-up time of 40 months. The patients were examined every 6 months with a standardized set of conventional liver function tests, and a liver biopsy was performed every year. The hyaluronate concentration correlated significantly (p < 0.001) with albumin, t 1/2 galactose tolerance test, bilirubin and prothrombin time but not to serum variables reflecting inflammatory activity. Furthermore, there was a close correlation between serum hyaluronate levels and histopathological changes in the liver. The hyaluronate concentration increased significantly over time in all clinical stages of primary biliary cirrhosis (p < 0.01), whereas the conventional liver function tests only changed in the advanced cases. The present data indicate that serum hyaluronate may be a sensitive marker for progressive liver damage in primary biliary cirrhosis. Serial determinations of hyaluronate are therefore of potential value for monitoring liver function during clinical management of the condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyaluronic acid was the first marker to show significant association with clinical outcomes [81,82].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [81]
In the citing paper
“Hyaluronic acid was the first marker to show significant association with clinical outcomes [81,82].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [81]
Citations
Cites
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Roll, J., Boyer, J. L., Barry, D., & Klatskin, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080101 · Cited by 417
Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells
Smedsrød, B., Pertoft, H., Eriksson, S., Fraser, J. R. E., & Laurent, T. C. (1984) · Biochemical Journal · doi:10.1042/bj2230617 · Cited by 297
Increased Serum Levels of Hyaluronate in Liver Disease
Engström-Laurent, A., Lööf, L., Nyberg, A., & Schröder, T. (1985) · Hepatology · doi:10.1002/hep.1840050420 · Cited by 243
Self-citationConcentration of sodium hyaluronate in serum
Engström-Laurent, A., Laurent, U. B. G., Lilja, K., & Laurent, T. C. (1985) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518509155249 · Cited by 228
Engström-Laurent, A., & Hällgren, R. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.2.83 · Cited by 204
ELIMINATION OF HYALURONIC ACID FROM THE BLOOD STREAM IN THE HUMAN
Fraser, J. R. E., Laurent, T. C., Engström‐Laurent, A., & Laurent, U. G. B. (1984) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1984.tb00235.x · Cited by 192
Asymptomatic primary biliary cirrhosis
Beswick, D. R., Klatskin, G., & Boyer, J. L. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90325-7 · Cited by 148
Engström‐Laurent, A., & Hällgren, R. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301203 · Cited by 141
Beswick, D. R., Klatskin, G., & Boyer, J. L. (1985) · PubMed · Cited by 117
Research works printed but not linked: 4
- James, 1981, Lancet, 1, 1278
- Scheuer, 1967, Proc R Soc Med, 60, 1257
- Fraser, 1986, J Lab Clin Med, 107, 79
- Sherlock, 1982, Scand J Gastroenterol, 17, 63
Cited by
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Noninvasive diagnosis of hepatic fibrosis or cirrhosis
Oberti, F., Valsesia, E., Pilette, C., Rousselet, M., Bedossa, P., Aube, C., Gallois, Y., Rifflet, H., Maiga, M., Penneau-Fontbonne, D., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9352863 · Cited by 375
McHutchison, J. G., Blatt, L. M., De Medina, M., Craig, J. R., Conrad, A., Schiff, E. R., Tong, M. J., & Group, T. C. I. S. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02233.x · Cited by 229
Pilette, C., Rousselet, M. C., Bedossa, P., Chappard, D., Oberti, F., Rifflet, H., Maïga, M. Y., Gallois, Y., & Calès, P. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80318-8 · Cited by 205
Serum Hyaluronan as a Disease Marker
Laurent, T. C., Laurent, U. B. G., & Fraser, J. R. E. (1996) · Annals of Medicine · doi:10.3109/07853899609033126 · Cited by 175
Parés, A. R., Deulofeu, R., Giménez, A., Caballería, L., Bruguera, M., Caballería, J., Ballesta, A. M., & Rodés, J. (1996) · Hepatology · doi:10.1002/hep.510240615 · Cited by 163
Liver fibrosis: perspectives in pathobiochemical research and clinical outlook.
Gressner, A. M. (1991) · PubMed · Cited by 142
Wiesner, R. H., Porayko, M. K., Dickson, R. E., Gores, G. J., LaRusso, N. F., Hay, E. J., Wahlstrom, E. H., & Krom, R. A. F. (1992) · Hepatology · doi:10.1002/hep.1840160527 · Cited by 142
The Hyaluronidases: A Chemical, Biological and Clinical Overview.
Frost, G. I., Csóka, T. B., & Stern, R. (1996) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.8.419 · Cited by 128
Guechot, J., Loria, A., Serfaty, L., Giral, P., GIBOUDEAU, J., & Poupon, R. Y. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80255-x · Cited by 126
Danielsson, Å., Boqvist, L., & Uddenfeldt, P. (1990) · Hepatology · doi:10.1002/hep.1840110317 · Cited by 122
Kaneda, H., Hashimoto, E., Yatsuji, S., Tokushige, K., & Shiratori, K. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04447.x · Cited by 119
Zhang, M., Song, G., & Minuk, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613004 · Cited by 111
Serum hyaluronate reflects hepatic sinusoidal capillarization
Ueno, T., Inuzuka, S., Torimura, T., Tamaki, S., Koh, H., Kin, M., Minetoma, T., Kimura, Y., Ohira, H., Sata, M., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90722-o · Cited by 110
Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis
Guechot, J., Serfaty, L., Bonnand, A.-M., Chazouillères, O., Poupon, R. E., & Poupon, R. Y. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80396-7 · Cited by 100
Michael, D. R., Phillips, A. O., Krupa, A., MARTIN, J. T., Redman, J. E., Al-Taher, A., Neville, R. D., Webber, J. P., Kim, M., & Bowen, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.233916 · Cited by 99
Guechot, J., Poupon, R. E., Giral, P., Balkau, B., GIBOUDEAU, J., & Poupon, R. Y. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80013-8 · Cited by 96
Biochemical markers of hepatic fibrosis
Plebani, M., & Burlina, A. (1991) · Clinical Biochemistry · doi:10.1016/0009-9120(91)80013-s · Cited by 94
Natural history of primary biliary cirrhosis
Parés, A., & Rodés, J. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00100-4 · Cited by 89
Yagmur, E., Tacke, F., Weiß, C., Lahme, B., Manns, M. P., Kiefer, P., Trautwein, C., & Gressner, A. M. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.07.016 · Cited by 85
Hyaluronan in intestinal homeostasis and inflammation: implications for fibrosis
de la Motte, C. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00063.2011 · Cited by 84
Role of hyaluronidase in Streptococcus intermedius biofilm
Pecharki, D., Petersen, F. C., & Scheie, A. A. (2008) · Microbiology · doi:10.1099/mic.0.2007/012393-0 · Cited by 80
Tamaki, S., Ueno, T., Torimura, T., Sata, M., & Tanikawa, K. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70074-4 · Cited by 78
Haserodt, S., Aytekin, M., & Dweik, R. A. (2010) · Glycobiology · doi:10.1093/glycob/cwq145 · Cited by 76
Montazeri, G., Estakhri, A., Mohamadnejad, M., Nouri, N., Montazeri, F., Mohammadkani, A., Derakhshan, M. H., Zamani, F., Samiee, S., & Malekzadeh, R. (2005) · BMC Gastroenterology · doi:10.1186/1471-230x-5-32 · Cited by 76
Ramadori, G. P., Zöhrens, G., Manns, M. P., RIEDER, H., Dienes, H. P., Hess, G., & Büschenfelde, K. ‐. M. Z. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01377.x · Cited by 73
Jiang, G., Wang, B., Wang, Y., Kong, H., Wang, Y., Gao, P., Guo, M., Li, W., Zhang, J., Wang, Z., et al. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120781 · Cited by 72
Hemodynamic and Liver Function Predictors of Serum Hyaluronan in Alcoholic Liver Disease
Gibson, P. R., Fraser, R. J., Brown, T. J., Finch, C. F., Jones, P. A., Colman, J. C., & Dudley, F. J. (1992) · Hepatology · doi:10.1002/hep.1840150614 · Cited by 72
Guffroy, M., Falahatpisheh, H., Biddle, K. E., Kreeger, J., Obert, L., Walters, K. M., Goldstein, R., Boucher, G., Coskran, T., Reagan, W. J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0939 · Cited by 71
Endothelial Cell Transformation in Primary Biliary Cirrhosis: A Morphological and Biochemical Study
Babbs, C., Haboubi, N. Y., Mellor, J. M., Smith, A., Rowan, B. P., & Warnes, T. W. (1990) · Hepatology · doi:10.1002/hep.1840110503 · Cited by 71
Gao, H.-Y., Li, G., Lou, M.-M., Li, X., Wei, X., & Wang, J. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-16 · Cited by 68
Clinical significance of serum hyaluronan in patients with chronic viral liver disease
Murawaki, Y., Ikuta, Y., Koda, M., Nishimura, Y., & Kawasaki, H. (1996) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1996.tb00291.x · Cited by 67
Lainé, F., Bendavid, C., Moirand, R., Tessier, S., Perrin, M., Guillygomarc’h, A., Guyader, D., Calon, E., Renault, A., Brissot, P., et al. (2004) · Hepatology · doi:10.1002/hep.20219 · Cited by 66
Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease
Pereira, T. N., Lewindon, P. J., Smith, J. L., Murphy, T. L., Lincoln, D. J., Shepherd, R. W., & Ramm, G. A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.032 · Cited by 65
Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury
George, J., & Stern, R. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.05.018 · Cited by 62
Serum hyaluronate correlates with histological progression in alcoholic liver disease
Stickel, F., Pöschl, G., Schuppan, D., Conradt, C., Strenge-Hesse, A., Fuchs, F. S., Hofmann, W. J., & Seitz, H. K. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200309000-00002 · Cited by 60
Serum hyaluronan and aminoterminal propeptide of type III procollagen: Variation with age
Lindqvist, U. R. C., & Laurent, T. C. (1992) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519209115504 · Cited by 60
Cumulus Cell Expansion, Its Role in Oocyte Biology and Perspectives of Measurement: A Review
Nevoral, J., Orsák, M., Klein, P., Petr, J., Dvořáková, M., Weingartová, I., Vyskocilova, A., Zámostná, K., Krejčová, T., & Jílek, F. (2015) · Scientia Agriculturae Bohemica · doi:10.1515/sab-2015-0002 · Cited by 59
Changes in Hyaluronan Concentration in Tissues and Body Fluids in Disease States
Engström‐Laurent, A. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513774.ch14 · Cited by 59
Poupon, R. E., Balkau, B., Guéchot, J., & Heintzmann, F. (1994) · Hepatology · doi:10.1002/hep.1840190314 · Cited by 58
Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies
Orasan, O. H., Ciulei, G., Cozma, A., Sava, M., & Dumitrascu, D. L. (2015) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-554 · Cited by 56
Regulation of hyaluronate synthesis in rat liver fat storing cell cultures by Kupffer cells
Gressner, A. M., & Haarmann, R. (1988) · Journal of Hepatology · doi:10.1016/s0168-8278(88)80003-5 · Cited by 56
Hepatic fibrosis: Are any of the serum markers useful?
Oh, S., & Afdhal, N. H. (2001) · Current Gastroenterology Reports · doi:10.1007/s11894-001-0035-2 · Cited by 54
Wiesner, R. H. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.6.575 · Cited by 52
Jalan, R., Sargentoni, J., Coutts, G. A., Bell, J. D., Rolles, K., Burroughs, A. K., & Taylor-Robinson, S. D. (1996) · Gut · doi:10.1136/gut.39.1.141 · Cited by 52
He, Y., Wu, G. D., Sadahiro, T., Noh, S.-I., Wang, H., Talavera‐Adame, D., Wang, H., Vierling, J. M., & Klein, A. S. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90229.2008 · Cited by 51
Serum hyaluronate as a marker of hepatic derangement in acute liver damage
Bramley, P. N., Rathbone, B. J., Forbes, M. A., Cooper, E. H., & Losowsky, M. S. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90856-7 · Cited by 50
Referral of patients with primary biliary cirrhosis for liver transplantation.
Neuberger, J., Gunson, B. K., Buckels, J. A., Elias, E., & McMaster, P. (1990) · Gut · doi:10.1136/gut.31.9.1069 · Cited by 49
Mechanisms by which food intake elevates circulating levels of hyaluronan in humans
Fraser, J. R. E., & GIBSON, P. R. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01564.x · Cited by 48
Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats
George, J., Tsutsumi, M., & Takase, S. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00253-x · Cited by 48
Shimizu, H., He, W., Guo, P., Dziadkoviec, I., Miyazaki, M., & Falk, R. E. (1994) · Hepatology · doi:10.1002/hep.1840200533 · Cited by 45
Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease
Wyatt, H., Dhawan, A. K., Cheeseman, P., Mieli-Vergani, G., & Price, J. F. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.86.3.190 · Cited by 43
Midgley, A. C., Duggal, L., Jenkins, R. L., Hascall, V. C., Steadman, R., Phillips, A. O., & Meran, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.625939 · Cited by 40
Satoh, T., Ichida, T., Matsuda, Y., Sugiyama, M., Yonekura, K., Ishikawa, T., & Asakura, H. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02164.x · Cited by 40
Cao, Y., Liu, X., & Guo, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-45785-w · Cited by 38
Ichida, T., Sugitani, S., Satoh, T., Matsuda, Y., Sugiyama, M., Yonekura, K., Ishikawa, T., & Asakura, H. (1996) · Liver International · doi:10.1111/j.1600-0676.1996.tb00763.x · Cited by 38
Primary biliary cirrhosis: new perspectives in diagnosis and treatment
Prince, M. I., & Jones, D. E. J. (2000) · Postgraduate Medical Journal · doi:10.1136/pmj.76.894.199 · Cited by 38
Measurement of serum hyaluronic acid as a sensitive marker of liver fibrosis in biliary atresia
Hasegawa, T., Sasaki, T., Kimura, T., Hoki, M., Okada, A., Mushiake, S., Yagi, M., & Imura, K. (2000) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2000.18342 · Cited by 37
Chen, W., Ma, I.-H., Chen, L., Tu, W.-H., Lu, C.-J., & Huang, C.-J. (2017) · Taiwan Journal of Ophthalmology · doi:10.4103/tjo.tjo_102_17 · Cited by 33
A Pharmacokinetic Model of Intravenously Administered Hyaluronan in Sheep
Lebel, L., Fraser, J. R. E., Kimpton, W. S., Gabrielsson, J., Gerdin, B., & Laurent, T. C. (1989) · Pharmaceutical Research · doi:10.1023/a:1015982204926 · Cited by 33
Yamada, M. G., Fukuda, Y., KOYAMA, Y., Nakano, I., Urano, F., Katano, Y., & Hayakawa, T. (1996) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1996.tb00308.x · Cited by 33
Nyberg, A. H., Lindqvist, U. R. C., & Engström‐Laurent, A. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00964.x · Cited by 33
Self-citationHyaluronan in canine arthropathies
Arican, M., Carter, S. D., May, C., & Bennett, D. (1994) · Journal of Comparative Pathology · doi:10.1016/s0021-9975(05)80050-7 · Cited by 32
Trivedi, P., Dhawan, A. K., Risteli, J., Risteli, L., Mirza, M. M., Cheeseman, P., & Mowat, A. P. (1995) · Pediatric Research · doi:10.1203/00006450-199510000-00016 · Cited by 30
Kredel, M., Muellenbach, R. M., Brock, R. W., Wilckens, H., Brederlau, J., Roewer, N., & Wunder, C. (2007) · Critical Care · doi:10.1186/cc5674 · Cited by 29
Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B
Pontinha, N., Pessegueiro, H., & Barros, H. (1999) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519950185535 · Cited by 29
Wong, C. S., & Gibson, P. R. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.tb00608.x · Cited by 29
Dynamic Hyaluronan drives liver endothelial cells towards angiogenesis
Ghose, S., Biswas, S., Datta, K., & Tyagi, R. K. (2018) · BMC Cancer · doi:10.1186/s12885-018-4532-1 · Cited by 28
Is serum hyaluronan a helpful tool in the management of patients with liver diseases?
Lindqvist, U. R. C. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00176.x · Cited by 28
Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation
Fried, M., Duncan, A., Soroka, S., Connaghan, D. G., Farrand, A. L., Peter, J. A., Strauss, R., Td, B., & McDonald, G. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702821 · Cited by 27
Gibson, P. R., Fraser, J. R. E., Colman, J. C., Jones, P. A., Jennings, G., & Dudley, F. J. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90721-n · Cited by 27
Floreani, A., Zappalà, F., Mazzetto, M. O., Naccarato, R., Plebani, M., & Chiaramonte, M. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02090053 · Cited by 27
Clinical Significance of the Immunometric Measurements of Hyaluronic Acid
Cooper, E. H., & Rathbone, B. J. (1990) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329002700505 · Cited by 27
Hyaluronic Acid in Vascular and Immune Homeostasis during Normal Pregnancy and Preeclampsia
Зиганшина, М. М., Pavlovich, S. V., Bovin, N. V., & Sukhikh, G. T. (2016) · Acta Naturae · doi:10.32607/20758251-2016-8-3-59-71 · Cited by 26
Predicting factor of quality of life in long-term jaundice-free survivors after the Kasai operation
Uchida, K., Urata, H., Suzuki, H., Inoue, M., Konishi, N., Araki, T., Miki, C., & Kusunoki, M. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2004.03.055 · Cited by 26
Characteristics of Serum Hyaluronate Concentrations in Patients with Alcoholic Liver Disease
Tsutsumi, M., Urashima, S., Takase, S., Ueshima, Y., Tsuchishima, M., Shimanaka, K., & Kawahara, H. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb04513.x · Cited by 26
Trivedi, P., Cheeseman, P., & Mowat, A. P. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90246-z · Cited by 26
Westerberg, G., Bergström, M., Gustafson, S., Lindqvist, U. R. C., Sundin, A., & Långström, B. (1995) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(94)00091-w · Cited by 25
Assessment of Liver Allograft Function by Hyaluronic Acid and Endothelin Levels
Suehiro, T., Boros, P., Emre, S., Sheiner, P. A., Guy, S. R., Schwartz, M., & Miller, C. M. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1997.5221 · Cited by 24
Salivary and serum hyaluronic acid concentrations in patients with Sjögren's syndrome
Tishler, M., Yaron, I., Shirazi, I., & Yaron, M. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.8.506 · Cited by 24
Immunohistochemical Study of Hyaluronate Receptor (CD44) in Alcoholic Liver Disease
Urashima, S., Tsutsumi, M., Ozaki, K., Tsuchishima, M., Shimanaka, K., Ueshima, Y., & Takase, S. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb00009.x · Cited by 24
Prognostic relevance of serum hyaluronan levels in patients with breast cancer
Ponting, J., Howell, A., Pye, D. A., & Kumar, S. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520607 · Cited by 22
Rao, P. N., Bronsther, O. L., Pinna, A. D., Snyder, J. T., Cowan, S. W., Sankey, S., Kramer, D. J., Takaya, S., & Starzl, T. E. (1996) · Liver International · doi:10.1111/j.1600-0676.1996.tb00703.x · Cited by 22
Takamatsu, S., Nakabayashi, H., Okamoto, Y., & Nakano, H. (1997) · Journal of Gastroenterology · doi:10.1007/bf02934493 · Cited by 22
Moreno‐Otero, R., Lisker‐Melman, M., & Jones, E. A. (1989) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30645-9 · Cited by 22
Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis?
Mutimer, D., Bassendine, M. F., Kelly, P., & James, O. (1989) · Journal of Hepatology · doi:10.1016/0168-8278(89)90049-4 · Cited by 22
Agroudy, A. E. E., Elghareb, M. S., Addissouky, T. A., Elshahat, E. H., & Hafez, E. (2016) · Journal of Bioscience and Applied Research/Journal of Bioscience and Applied Research · doi:10.21608/jbaar.2016.108377 · Cited by 21
A hyaluronan-loading test applied to patients with liver and joint diseases
Lindqvist, U. R. C., Groth, T., Lööf, L., & Hellsing, K. (1992) · Clinica Chimica Acta · doi:10.1016/0009-8981(92)90050-z · Cited by 21
Self-citationSerum hyaluronic acid as an early prognostic marker in biliary atresia
Dhawan, A. K., Trivedi, P., Cheeseman, P., Baker, A., Howard, E. R., & Mieli‐Vergani, G. (2001) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2001.21622 · Cited by 21
Prognostication in primary biliary cirrhosis: Relevance to the individual patient
Christensen, E. (1989) · Hepatology · doi:10.1002/hep.1840100121 · Cited by 21
三枝, 庄., Isaji, S., & Kawarada, Y. (2002) · World Journal of Surgery · doi:10.1007/s00268-001-0292-0 · Cited by 20
Biochemical markers of hepatic fibrosis in primary biliary cirrhosis
Plebani, M., Giacomini, A., Floreani, A., Chiaramonte, M., Soffiati, G., Naccarato, R., & Burlina, A. (1990) · La Ricerca in Clinica e in Laboratorio · doi:10.1007/bf02900712 · Cited by 20
Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases
Corpechot, C. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.013 · Cited by 19
Kwon, S.-B., Park, J.-S., Yi, J.-Y., Hwang, J.-W., Kim, M., Lee, M., Lee, B., Kim, H., Kim, J. H., Chung, H., et al. (2008) · Toxicologic Pathology · doi:10.1177/0192623308320272 · Cited by 19
Risk stratification and prognostic modelling in primary biliary cholangitis
Goet, J. C., Harms, M. H., Carbone, M., & Hansen, B. E. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.06.006 · Cited by 19
Primary biliary cirrhosis: survival of a cohort followed for 10 years
Uddenfeldt, P., & Danielsson, A. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00733.x · Cited by 16
[11C]Hyaluronan uptake with positron emission tomography in liver disease
Lindqvist, Westerberg, Bergström, Torsteindottir, Gustafson, Sundin, Lööf, & Långström (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00675.x · Cited by 16
Histochemical Study of Hyaluronate in Alcoholic Liver Disease
Urashima, S., Tsutsumi, M., Shimanaka, K., Ueshima, Y., Tsuchishima, M., Itoh, T., Kawahara, H., & Takase, S. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04535.x · Cited by 16
Follow‐up of the serum levels of extracellular matrix components in acute and chronic pancreatitis
Adler, G., Kröpf, J., Grobe, E., & Gressner, A. M. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01891.x · Cited by 15
Assessment of new hyaluronic acid assays and their impact on FibroMeter scores
Veillon, P., Gallois, Y., Moal, V., Fouchard‐Hubert, I., Isabelle, C., Larcher, F., Dib, N., Boursier, J., Oberti, F., Laafi, J., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.11.009 · Cited by 14
Metadata
- Authors
- Nyberg, A., Engström-Làurent, A., & Lööf, L.
- Affiliations
- Uppsala University Hospital (SE)
- Corresponding author
- Nyberg, Anders
- ORCID
- Nyberg, Anders
- Venue
- Hepatology
- Published
- 1988-01
- Volume
- 8
- Issue
- 1
- Pages
- 142-146
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2073402254
- Semantic Scholar
- b93d1eecf8d27c66ec88414c008cc1e9651e67a5
- Cited by
- 134
- References
- 18
- Citations by year
- 2025: 1 · 2023: 1 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 4 · 2012: 1
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 10105 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- primary biliary cirrhosis, biochemical markers, liver function monitoring, liver histopathology, liver biopsy, serum albumin, prothrombin time, bilirubin, galactose tolerance test
- MeSH terms
- Biopsy, Female, Follow-Up Studies, Humans, Hyaluronic Acid, Liver, Liver Cirrhosis, Biliary, Liver Function Tests, Longitudinal Studies, Male, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.